Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 23, 2013
[Anxiety disorder]Maiko Hayashida, Jun HoriguchiChemical & Pharmaceutical Bulletin|September 2, 2006
Investigation of selective mono-deallylation of O,O'-diallylcatechols and 3-methylene-1,5-benzodioxepanesMaiko Hayashida, Miyuki Ishizaki, Hiroshi HaraCase Reports in Psychiatry|April 3, 2019
Decreased <i>Clostridium</i> Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with SchizophreniaMisako Kanayama, Maiko Hayashida, Sadayuki Hashioka, et al.Psychiatry Research|August 28, 2007
Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophreniaRei Yasukawa, Tsuyoshi Miyaoka, Hideaki Yasuda, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 13, 2006
Possible antipsychotic effects of minocycline in patients with schizophreniaTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.International Journal of Molecular Sciences|July 27, 2022
Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for LymphedemaRyohei Ogino, Tomoharu Yokooji, Maiko Hayashida, et al.Case Reports in Psychiatry|June 5, 2018
Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive TherapyMisako Kanayama, Tsuyoshi Miyaoka, Tomoko Araki, et al.Clinical Neuropharmacology|October 7, 2008
Minocycline as adjunctive therapy for schizophrenia: an open-label studyTsuyoshi Miyaoka, Rei Yasukawa, Hideaki Yasuda, et al.Leukemia & Lymphoma|February 28, 2022
Prediction of the risk for graft <i>versus</i> host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumabYuhei Kamada, Naosuke Arima, Maiko Hayashida, et al.Frontiers in Neuroscience|August 4, 2018
Implications of Systemic Inflammation and Periodontitis for Major DepressionSadayuki Hashioka, Ken Inoue, Maiko Hayashida, et al.Pageof 5